Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Clears Asterias to Begin Stem Cell Trial
Drug Discovery and Development
Thursday, August 28, 2014 - 8:54am
tags:
FDA, Asterias, clinical trials, stem cells, AST-OPC1
Repros says its testosterone drug found superior in study
Yahoo/Reuters
Thursday, August 28, 2014 - 8:52am
tags:
testosterone, Repros Therapeutics, Androxal
FDA says Johnson & Johnson recalls some jaw implants
Yahoo/Reuters
Thursday, August 28, 2014 - 8:51am
tags:
jaw implants, devices, JNJ, FDA, recalls
Worth the Money? Assessing Executive Pay at Specialty Drug Makers
WSJ Pharmalot
Wednesday, August 27, 2014 - 6:47pm
tags:
executive pay
Allergan v Valeant: When Will It End?
Barron's
Wednesday, August 27, 2014 - 5:09pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Valeant, Ackman get Oct. 6 trial over Allergan special meeting
Yahoo/Reuters
Wednesday, August 27, 2014 - 5:08pm
tags:
Bill Ackman, Allergan, M&A, Valeant Pharmaceuticals
Jaguar Animal Health Files for IPO
24/7 Wall St
Wednesday, August 27, 2014 - 5:06pm
tags:
IPOs, animal health, Jaguar Animal Health
Glaxo’s Ebola Vaccine to Be Tested for Safety in Humans
Bloomberg
Wednesday, August 27, 2014 - 5:04pm
tags:
vaccines, ebola virus, GSK, Tekmira Pharmaceuticals, NewLink Genetics
The Palbociclib Saga: Or Why We Need a Lot of Drug Companies
In the Pipelline
Wednesday, August 27, 2014 - 10:55am
tags:
palbociclib, Pfizer
Big Pharma, Big Biotech prepare for showdown in next-gen psoriasis market
Fierce Pharma Marketing
Wednesday, August 27, 2014 - 10:22am
tags:
Embrel, Amgen, Pfizer, Eli Lilly, Novartis, Celgene, psoriasis, AstraZeneca
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wednesday, August 27, 2014 - 10:19am
tags:
Bristol-Myers Squibb, Gilead Sciences, hepatitis C, Daklinza, Sovaldi
Teva recalls Parkinson's disease drug because it may be 'superpotent'
Fierce Pharma Manufacturing
Wednesday, August 27, 2014 - 10:11am
tags:
Teva Pharmaceuticals, Parkinson's Disease, carbidopa/levodopa
Roche, InterMune a Strategic Play in Midst of Inversions
TheStreet.com
Wednesday, August 27, 2014 - 10:08am
tags:
Roche, InterMune, tax inversions, M&A
Who can Recall what FDA’s Mandatory Recall Authority is? A U.S. District Court Could Not…
FDA Law Blog
Wednesday, August 27, 2014 - 10:04am
tags:
FDA, recalls, mandatory recalls
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure
Yahoo
Wednesday, August 27, 2014 - 10:00am
tags:
FDA, chronic heart failure, Amgen, ivabradine
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch
Investors.com
Wednesday, August 27, 2014 - 9:55am
tags:
Jazz Pharmaceuticals, Gilead Sciences, Illumina, Salix
Analysts' Actions: Akamai, Bristol-Myers, Eli Lilly, Merck, Pfizer
Yahoo/The Street
Wednesday, August 27, 2014 - 9:52am
tags:
Akamai, Bristol-Myers Squibb, Merck, Eli Lilly, Pfizer
PhRMA jumps into Integrilin off-label case, free-speech arguments at the ready
Fierce Pharma Marketing
Wednesday, August 27, 2014 - 8:51am
tags:
PhRMA, off-label, free speech, Integrilin, Merck, Schering Plough, Millennium Pharmaceuticals
Commonly Prescribed Sleeping Aid Linked To Doubling of Emergency Department Visits
Forbes
Wednesday, August 27, 2014 - 8:28am
tags:
Ambien, insomnia
Venus Remedies surges; to collaborate with Teva on drug
Yahoo/Reuters
Wednesday, August 27, 2014 - 8:21am
tags:
Venus Remedies, Teva Pharmaceutical, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.